Clinical Trial Update: Evaluation of Performance and Safety of Carbopol 980 NF 0.2%- Based Medical Device in the Management of Patients With Glaucomar or Ocular Hypertension and Concomitant Dry Eye Syndrome on Multiple Long-term Topical Hypotensive Therapy [NA]

View source ↗

Summary

A clinical trial evaluating a Carbopol 980 NF 0.2% based medical device for managing Dry Eye Syndrome in patients with Glaucoma or Ocular Hypertension on long-t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome
• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Carbopol 980 NF 0.2% Based Medical Device (Carbopol 980 NF)

Snippet

Sponsor: Fidia Farmaceutici s.p.a. | Conditions: Dry Eye Syndrome, Glaucoma and Concomitant Dry Eye Syndrome | NA | Status: TERMINATED